Details - Information last confirmed on June 23, 2021
First Of Its Kind Clinical Pharmacy App Portfolio
Proven To Reduce Medication Errors And Improve Patient Care
Enter a unique solution to reduce errors in the healthcare industry while reducing costs and improving the overall level of patient care. This Clinical Pharmacy Service Company with its current product line is well equipped to become a game changer in the healthcare industry with its cutting-edge applications much unlike any on the market.
Portfolio of applications represents the first comprehensive set of applications that allows its clients to calculate appropriate dosing of TDM meds including loading doses and determining hold times after drug overdose. Improves overall patient care by reducing hospital stay and reduces morbidity and mortality. Compare outcomes data of antiplatelet agents. Quantitatively compare differences between drug products for formulary decision-making. Reduce medication errors and ADR’s and demonstrate cost savings of various clinical interventions.
Clients will have a comprehensive clinical pharmacy platform to provide pharmacokinetics, monitor ADR’s, med errors, track clinical interventions & provide formulary management with the portfolio of clinical apps.
The Clinical Pharmacy Portfolio has been recognized by JCAHO for its outstanding analytics and QA Reporting. The applications allow for dosage calculations for several TDM medications, tracking and trending medication errors and ADR’s, documenting impact of clinical interventions as well as analyzing quantitative differences between drug products as part of the formulary decision making process. This combination of clinical apps readily reduces med errors and improves the level of patient care.
Simply assuming very modest market share numbers makes this portfolio a valuable commodity with the potential for recurring revenue with annual subscription upgrades.
Sign up for a free membership. Get instant access to thousands of listings. Learn about our membership plans.
Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness. This listing does not constitute an offer to sell, solicit or make an offer to buy an investment interest. Offers to sell, or the solicitation of offers to buy, any security can only be made through official offering documents, such as a subscription agreement and private placement memorandum.